This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Kenneth S Bembenek: Innovator in Pediatric Formulations
Introduction
Kenneth S Bembenek is a notable inventor based in Dayton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing formulations that cater to pediatric needs. His innovative approach has led to advancements in the way medications are administered to children.
Latest Patents
Bembenek holds a patent for a pediatric formulation of gatifloxacin. This invention provides a quinolone antibacterial agent that is adequately taste-masked, making it suitable for pediatric formulations. The patent describes a crystalline co-precipitate of gatifloxacin combined with stearic acid and palmitic acid in a specific weight ratio. This formulation effectively masks the bitter taste of gatifloxacin, ensuring that it is palatable for children. The taste-masking is effective throughout a full dosage cycle, typically lasting fourteen days. Furthermore, the gatifloxacin in these crystalline co-precipitates is readily available for absorption from the stomach, enhancing its efficacy.
Career Highlights
Bembenek's career is marked by his dedication to improving pediatric medicine. His work at Bristol-Myers Squibb Company has allowed him to focus on developing formulations that address the unique challenges of treating children. His innovative solutions have the potential to improve compliance and health outcomes in pediatric patients.
Collaborations
Throughout his career, Bembenek has collaborated with esteemed colleagues, including Veronique Trognon and Richard G Corrao. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Kenneth S Bembenek's contributions to pediatric formulations exemplify the importance of innovation in medicine. His work not only addresses the challenges of taste in medications for children but also enhances their overall treatment experience. His patent for the taste-masked gatifloxacin formulation is a testament to his commitment to improving pediatric healthcare.